Defined Cell Culture Highlights:
Cardiac Maturation, Forebrain Organoids, & Airway Function
November 9-15, 2026
This week’s research showed how chemically defined media, extracellular matrices, developmental timing, and quantitative functional assays can improve the maturity and relevance of human pluripotent stem cell-derived models. Studies spanning cardiomyocytes, forebrain organoids, and airway epithelium demonstrated that cell identity alone is not enough. Culture systems must also reproduce appropriate metabolism, mechanics, electrophysiology, and tissue-level function.
Chemically defined medium promotes adult-like cardiomyocyte metabolism
A Circulation study published November 10 developed a chemically defined medium designed to improve the metabolic maturity of human iPSC-derived cardiomyocytes.
The researchers used bioinformatics to identify transcriptional markers that distinguish adult cardiac metabolism, then developed an 11-component maturation medium called MM11. After two weeks of treatment, iPSC-derived cardiomyocytes increased the expression of pathways associated with mitochondrial respiration and fatty acid metabolism.
The cells developed interfibrillar mitochondria and mitochondrial respiratory supercomplexes, structural features associated with adult cardiomyocytes. Oxygen consumption measurements and C13 tracing also showed increased oxidative phosphorylation and a greater ability to use fatty acids in the presence of physiological substrates.
Researchers benchmarked the cells against primary adult human cardiomyocytes and used the matured cultures to model ischemia-reperfusion injury and Friedreich ataxia-associated cardiomyopathy.
This work illustrates how media can be designed around a specific functional objective. For cardiac models, maturation can be evaluated using metabolic flux, mitochondrial organization, and substrate utilization rather than relying only on cardiac marker expression or spontaneous contraction.
Read the study here.
Enhancer-targeted CRISPR activation rescues phenotypes in forebrain organoids
A Nature Neuroscience study published November 13 investigated whether enhancer-targeted gene activation could correct haploinsufficiency in human PSC-derived models of autism.
The researchers mapped developmental enhancers associated with CHD8 and SCN2A, two dosage-sensitive genes linked to neurodevelopmental disorders. They then used CRISPR activation to target these enhancers in hPSC-derived excitatory neurons and cerebral forebrain organoids.
Enhancer targeting increased CHD8 or SCN2A expression primarily in mutant cells while producing little change in wild-type controls. In CHD8-mutant organoids, treatment shifted transcriptional profiles toward the wild-type state and reduced abnormalities in neuronal differentiation. In SCN2A-mutant neurons, treatment improved neuronal maturation and restored several electrophysiological measurements toward control levels.
The timing of treatment mattered; enhancers responded differently depending on the developmental stage of the organoids, consistent with their role in controlling when and where genes are expressed. The magnitude of rescue also depended on delivery efficiency, and some effects declined during extended culture.
The study demonstrates how long-term PSC-derived models can be valuable for evaluating genetic interventions. They can reveal whether a treatment preserves developmental regulation and restores functional phenotypes.
Read the open access paper here.
Forebrain organoids map altered cell fate regulation in autism
Similarly, a Nature Communications study published November 14 used patient-derived forebrain organoids to examine how enhancer activity controls neuronal lineage specification.
The researchers generated organoids from 10 male individuals with autism spectrum disorder and their neurotypical fathers. By integrating epigenomic and transcriptomic measurements across 60 days of differentiation, they constructed a gene regulatory network connecting transcription factors, enhancers, and neuronal cell fate genes.
The network identified FOXG1, BHLHE22, EOMES, and NEUROD2 as important regulators of excitatory neuron specification. Differences in their activity were associated with increased excitatory neuron production in organoids from individuals with macrocephalic autism and decreased production in organoids from individuals without macrocephaly. Selected regulatory relationships were tested using CRISPR interference and loss-of-function experiments.
This study also highlights the importance of measuring organoids longitudinally and at single-cell resolution. Differences in lineage proportions can reflect altered developmental trajectories rather than simple changes in a single marker or endpoint measurement.
Patient-derived organoids retain valuable genetic context, but they also introduce donor-dependent variability. Carefully matched comparisons, standardized differentiation, and quantitative cell composition measurements are therefore essential for distinguishing disease-associated effects from culture variation.
Read the study here.
Multiparametric assays connect iPSC phenotypes with clinical severity
A Nature Cardiovascular Research paper published November 13 introduced a higher-throughput platform for measuring how TNNI3 variants affect human iPSC-derived cardiomyocytes.
TNNI3 encodes cardiac troponin I, and variants in the gene can cause hypertrophic, restrictive, or dilated cardiomyopathy. Many identified variants remain difficult to interpret using genetic information alone.
The platform combined measurements of contractile force, calcium handling, and systolic and diastolic function. Testing a library of variants distinguished known pathogenic variants from benign and synonymous controls. It also provided functional evidence for the pathogenicity of variants previously classified as uncertain.
When researchers compared the in vitro results with clinical data, measurements of diastolic dysfunction correlated with age of disease onset, with an R-squared value of 0.6. Calcium sensitivity helped identify pathogenic variants but did not predict clinical severity as well as the diastolic measurements.
The findings show why PSC-derived models benefit from multiparametric functional testing. Different measurements can answer different questions, and the phenotype that identifies a disease-causing variant may not be the same phenotype that predicts disease severity.
Read the open access paper here.
Rare pulmonary ionocytes control function in iPSC-derived airway epithelium
An American Journal of Respiratory Cell and Molecular Biology study published November 13 used gene-edited iPSCs to investigate pulmonary ionocytes, a rare airway population with high CFTR expression.
In this study, researchers deleted FOXI1, a transcription factor required for ionocyte differentiation, and introduced a doxycycline-inducible FOXI1 expression system. The edited iPSCs were then differentiated into airway epithelium.
FOXI1 deletion prevented ionocyte formation, reduced chloride transport, increased mucus-producing goblet cells, and decreased ciliated cells. Restoring FOXI1 expression recovered CFTR-mediated chloride transport. Introducing inducible wild-type CFTR ionocytes into airway cultures carrying the F508del cystic fibrosis mutation also improved chloride transport.
Although ionocytes represent only a small fraction of airway epithelial cells, their removal affected both tissue composition and function. This illustrates why differentiation workflows should be evaluated for rare but functionally important populations. A culture can contain the major expected cell types while still lacking the cellular diversity needed to reproduce tissue-level physiology.
Read the study here.
Matrix identity determines how iPSC-derived cardiomyocytes sense stiffness
A Journal of Molecular and Cellular Cardiology study published online November 10 examined how extracellular matrix proteins influence mechanosensing in iPSC-derived cardiomyocytes.
The researchers cultured cardiomyocytes on hydrogels with stiffness values of 0.4, 7.9, or 60 kilopascals. The hydrogels were coated with either fibronectin or vitronectin.
On fibronectin, increasing substrate stiffness caused the cells to spread more extensively, form more mature focal adhesions, and develop better-organized sarcomeres. Cells cultured on vitronectin did not show the same stiffness-dependent structural changes.
The difference was linked to focal adhesion kinase signaling. Fibronectin supported stiffness-dependent FAK activation, while vitronectin did not. The results suggest that matrix composition determines whether cells can interpret and respond to the mechanical properties of their substrate.
Matrix identity and stiffness should therefore not be treated as independent culture variables. Two substrates with the same mechanical properties can produce different cellular responses because of differences in ligand binding and downstream signaling.
Read the paper here.
The week’s takeaway
A chemically defined medium moved iPSC-derived cardiomyocytes toward adult-like mitochondrial metabolism. Enhancer-targeted gene activation corrected molecular and functional phenotypes in forebrain organoids, while longitudinal profiling revealed altered neuronal lineage decisions in patient-derived autism models. Multiparametric cardiac assays connected in vitro physiology with clinical severity. Gene-edited airway cultures demonstrated the functional importance of rare pulmonary ionocytes, and matrix experiments showed that biochemical composition determines how cells respond to substrate stiffness.
Across these studies, the quality of a PSC-derived model depended on more than differentiation efficiency. Media composition, matrix identity, developmental timing, cellular diversity, and functional assay selection all influenced whether the resulting cells reproduced the biology required for their intended application.
Whether you are developing a PSC, organoid, cell therapy, or disease modeling workflow, reducing variability starts with well-characterized media and supplements. Defined Bioscience provides animal-free solutions and custom media development. Explore our products or contact us to discuss your workflow.
